UK markets close in 6 hours 5 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3400-0.0400 (-2.90%)
At close: 04:00PM EDT
1.3500 +0.01 (+0.75%)
Pre-market: 05:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 388.19M
Enterprise value 182.84M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.42
Price/book (mrq)1.25
Enterprise value/revenue 8.92
Enterprise value/EBITDA -1.97

Trading information

Stock price history

Beta (5Y monthly) 2.17
52-week change 3-79.64%
S&P500 52-week change 3-11.93%
52-week high 36.8800
52-week low 31.1600
50-day moving average 31.5702
200-day moving average 32.9597

Share statistics

Avg vol (3-month) 36.4M
Avg vol (10-day) 36.96M
Shares outstanding 5289.7M
Implied shares outstanding 6N/A
Float 8284.14M
% held by insiders 11.92%
% held by institutions 126.21%
Shares short (14 Jun 2022) 438.05M
Short ratio (14 Jun 2022) 46.91
Short % of float (14 Jun 2022) 413.14%
Short % of shares outstanding (14 Jun 2022) 413.13%
Shares short (prior month 12 May 2022) 439.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-460.19%

Management effectiveness

Return on assets (ttm)-16.09%
Return on equity (ttm)-27.43%

Income statement

Revenue (ttm)20.51M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)79.80%
Gross profit (ttm)3.87M
EBITDA -89.27M
Net income avi to common (ttm)-92.44M
Diluted EPS (ttm)-0.3280
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)216.47M
Total cash per share (mrq)0.75
Total debt (mrq)11.12M
Total debt/equity (mrq)3.57
Current ratio (mrq)12.99
Book value per share (mrq)1.07

Cash flow statement

Operating cash flow (ttm)-90.52M
Levered free cash flow (ttm)-50.28M